Knockdown of Sal-like 4 expression by siRNA induces apoptosis in colorectal cancer.
AmirReza HesariShadi RajabMarzieh RezaeiMaryam BasamSara GolmohamadiFaezeh GhasemiPublished in: Journal of cellular biochemistry (2019)
Colorectal cancer (CRC) is known as the third most common malignancies among men and women and is also the second leading cause of cancer-related deaths worldwide. It has been indicated that a variety of risk factors are involved in the pathogenesis of CRC. Spalt-like transcription factor 4 (SALL4) is known as a transcription factor that plays an important role in the proliferation of cancerous cells. In this study, using a specific sequence of small interfering RNA (siRNA) against the sequence of SALL4, its activity is investigated in the CRC cell line (sw742). The CRC cells (sw742) were cultured and then, using a specific anti-SALL4 siRNA, their toxic doses were determined. Then, the gene is transfected into the cell. Proliferation and expression of the SALL4 and Bcl-2 gene were measured using the real-time polymerase chain reaction method. Cell death was evaluated by propidium iodide staining and fluorescence-activated cell sorting analysis. Our results indicated that the specific concentration of siRNA of the SALL4 gene was 62.5 nmole. Gene expression of SALL4 and Bcl-2 results showed that expression of Bcl-2 gene in the siRNA group was significantly reduced. In conclusion, our finding indicated that it could be used as a therapeutic and diagnostic biomarker in the treatment of patients with CRC.
Keyphrases
- transcription factor
- genome wide identification
- poor prognosis
- cancer therapy
- cell death
- gene expression
- cell cycle arrest
- genome wide
- induced apoptosis
- copy number
- risk factors
- cell proliferation
- dna methylation
- signaling pathway
- binding protein
- hyaluronic acid
- single cell
- dna binding
- stem cells
- mesenchymal stem cells
- endothelial cells
- genome wide analysis
- cell cycle
- amino acid
- cell therapy
- endoplasmic reticulum stress
- oxidative stress
- combination therapy
- flow cytometry